| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0044 | 0.9 |